No CrossRef data available.
Article contents
The Value of Collaboration in Improving Knowledge on Rare Diseases
Published online by Cambridge University Press: 02 December 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Editorial
- Information
- Copyright
- Copyright © The Canadian Journal of Neurological 2011
References
1
Mah, JK, Selby, K, Campbell, C, et al.
A population-based study of dystrophin mutations in Canada. Can J Neurol Sci. 2011;38(3): 465–74.CrossRefGoogle ScholarPubMed
2
Bushby, K, Finkel, R, Birnkrant, DJ, et al.
Diagnosis and management of DuchenneMuscular Dystrophy, part 1: diagnosis and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77–93.CrossRefGoogle Scholar
3
Bushby, K, Lochmuller, H, Lynn, S, Straub, V.
Interventions for muscular dystrophy: molecular medicines entering the clinic. Lancet. 2009;374(9704):1849–56.CrossRefGoogle ScholarPubMed
4
Cunnif, C, Andrews, J, Meaney, FJ, et al.
Mutation analysis in a population based cohort of boys with Duchenne or Becker muscular dystrophy. J Child Neurol. 2009;24(4):425–30.CrossRefGoogle Scholar
5
Abbs, S, Tuffery-Giraud, S, Bakker, E, Ferlini, A, Sejersen, T, Mueller, CR.
Best practice guidelines on molecular testing in Duchenne and Becker muscular dystrophies. Neuromuscul Disord. 2010 Jun;20(6):422–7.CrossRefGoogle Scholar
You have
Access